Gastrointestinal bleeding in hepatocellular carcinoma under systemic therapy: Real-world incidence and clinical predictors
Highlights • GI bleeding occurred in 24.1% of HCC patients during systemic therapy.• GI bleeding reached 23.1% cumulative incidence at 12-months.• Varices, splenomegaly and vascular invasion predicted bleeding risk.• A simple 4-point score stratified GI bleeding risk during treatment.• GI bleeding was associated with 7...